Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...
Unlock the essentials of the earn 2025 earnings transcript. This plain‑speak guide breaks down what to listen for, ho...
Wells Fargo agreed to a $110 million discrimination settlement, prompting a cautious but constructive market response...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...
The day brought a notable jump in the QBTS stock as headlines pointed to potential funding. This guide breaks down wh...
Apple hits a fresh 52-week high as Services revenue climbs and iPhone demand remains strong. The move fuels a buy, ho...
A Google-backed pilot is testing a portal-like model that surfaces MLS-listed homes via search, changing how buyers a...
A nationwide labor crunch is tightening the screws on U.S. construction as immigrant workers pull back amid policy ch...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...